Respiratory Biology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
The Respiratory Biology Faculty has been created by grouping relevant Sections from other F1000 Faculties, it therefore does not have separate Heads of Faculty, Section Heads or Faculty Members.
The Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES) trial is a large, well-designed clinical study to determine whether addition of imatinib mesylate, a tyrosine kinase inhibitor that targets platelet-derived growth factor (PDGF...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
4 Recommendations, most recent by
Past 7 Days
New Articles Recommended
Past 30 Days
11Articles Classified As Controversial156 total
20Articles Classified As Novel Drug Target329 total
4Articles Classified As Confirmation233 total
4Articles Classified As Technical Advance184 total
31Articles Classified As New Finding1,136 total
16Articles Classified As Interesting Hypothesis336 total
4Articles Classified As Good for Teaching25 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.